Dopamine Transporter Imaging in Neurological Practice
Santa Clara, California, March 31, 2012
Dr. Caroline Tanner, Director of Clinical Research, The Parkinson’s Institute, Sunnyvale, California
The fourth Dopamine Transporter Imaging course in the U.S. was held in Santa Clara, CA, on March 31, 2012. Faculty and participants met at the Embassy Suites Santa Clara in the heart of Silicon Valley. In the morning session J. William Langston, the founder of The Parkinson’s Institute, gave an introductory talk on “Redefining Parkinson’s Disease” and Dr. Caroline Tanner, the Course Director, discussed “Biomarkers and Parkinson’s Disease: A Clinician’s Perspective”. Dr. Ramesh Gopi covered the principles, analysis and perspective of Dopamine Transporter Imaging, and Dr. Danna Jennings, who participated as faculty in all four U.S. DTI courses, presented on “Dopamine Transporter Imaging in Parkinson’s Disease and Related Disorders: Diagnosis and Differential Diagnosis”.
The afternoon session began by covering MRI and Parkinson’s Disease, presented by Dr. Norbert Schuff. The remainder of the afternoon covered practical considerations and clinical correlations of DTI as well as case study images. This course had 11 attendees with 7 attendees claiming CME credit. Although the course was small, the size lent well to discussions and debate on Dopamine Transporter Imaging.
This course was supported by an unrestricted educational grant from:
For more information contact